Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors.

IF 3.6 3区 医学 Q2 HEMATOLOGY Transplantation and Cellular Therapy Pub Date : 2024-08-23 DOI:10.1016/j.jtct.2024.08.012
Richard Newcomb, Lara Traeger, Bailey Jones, Mathew Reynolds, Alexandra Tse, Jennifer B Reese, Don Dizon, Sharon L Bober, Joseph A Greer, Julie Vanderklish, Nicole Pensak, Zachariah DeFilipp, Yi-Bin Chen, Jennifer S Temel, Areej El-Jawahri
{"title":"Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors.","authors":"Richard Newcomb, Lara Traeger, Bailey Jones, Mathew Reynolds, Alexandra Tse, Jennifer B Reese, Don Dizon, Sharon L Bober, Joseph A Greer, Julie Vanderklish, Nicole Pensak, Zachariah DeFilipp, Yi-Bin Chen, Jennifer S Temel, Areej El-Jawahri","doi":"10.1016/j.jtct.2024.08.012","DOIUrl":null,"url":null,"abstract":"<p><p>Hematopoietic stem cell transplant (HSCT) survivors frequently experience persistent sexual dysfunction, which is associated with impaired quality of life and increased psychological distress. The lack of availability of clinicians with expertise in sexual health limits the capacity to address sexual health concerns in HSCT survivors. Digital health applications may offer a patient-centered and scalable solution to address sexual health concerns in cancer survivors. The objective of this report is to delineate the iterative process of adapting an in-person sexual health intervention into a self-administered digital application called \"Sexual Health and Intimacy Following Transplant (SHIFT)\" and the refinement of SHIFT using stakeholder feedback. We used a five-step development model to adapt SHIFT that included: (1) implementation of a multimodal bio-psycho-social conceptual framework, (2) development of a comprehensive intervention manual and SHIFT content, (3) translation of the intervention manual into an interactive storyline with a focus on enhancing patient engagement, (4) creation of initial SHIFT wireframes, and (5) refinement of SHIFT through iterative alpha and beta testing. At each step, key stakeholders including HSCT survivors, HSCT clinicians, and experts in sexual health, psychology, and digital health provided iterative feedback. We adapted SHIFT based on our conceptual framework, prior in-person intervention work, and iterative stakeholder feedback in each application development stage. SHIFT incorporates medical information, educational materials, intimacy exercises, and activities to address the multiple etiologies of sexual health concerns in HSCT survivors. SHIFT includes strategies to enhance engagement including gamification, personalization, and incorporation of video from HSCT survivors and clinicians. Based on stakeholder feedback, SHIFT was refined with a focus on inclusivity of gender, sexual orientation, relationship status, and body image concerns. SHIFT is novel, patient-centered digital application to address sexual dysfunction in HSCT survivors. Iterative feedback from key stakeholders including HSCT survivors guided SHIFT adaptation and refinement, to optimize patient engagement and ensure inclusivity. The final prototype of SHIFT was initially acceptable to key stakeholders and is now under further testing in a pilot randomized trial to assess its feasibility and preliminary efficacy for improving sexual health outcomes in HSCT survivors.</p>","PeriodicalId":23283,"journal":{"name":"Transplantation and Cellular Therapy","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation and Cellular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtct.2024.08.012","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hematopoietic stem cell transplant (HSCT) survivors frequently experience persistent sexual dysfunction, which is associated with impaired quality of life and increased psychological distress. The lack of availability of clinicians with expertise in sexual health limits the capacity to address sexual health concerns in HSCT survivors. Digital health applications may offer a patient-centered and scalable solution to address sexual health concerns in cancer survivors. The objective of this report is to delineate the iterative process of adapting an in-person sexual health intervention into a self-administered digital application called "Sexual Health and Intimacy Following Transplant (SHIFT)" and the refinement of SHIFT using stakeholder feedback. We used a five-step development model to adapt SHIFT that included: (1) implementation of a multimodal bio-psycho-social conceptual framework, (2) development of a comprehensive intervention manual and SHIFT content, (3) translation of the intervention manual into an interactive storyline with a focus on enhancing patient engagement, (4) creation of initial SHIFT wireframes, and (5) refinement of SHIFT through iterative alpha and beta testing. At each step, key stakeholders including HSCT survivors, HSCT clinicians, and experts in sexual health, psychology, and digital health provided iterative feedback. We adapted SHIFT based on our conceptual framework, prior in-person intervention work, and iterative stakeholder feedback in each application development stage. SHIFT incorporates medical information, educational materials, intimacy exercises, and activities to address the multiple etiologies of sexual health concerns in HSCT survivors. SHIFT includes strategies to enhance engagement including gamification, personalization, and incorporation of video from HSCT survivors and clinicians. Based on stakeholder feedback, SHIFT was refined with a focus on inclusivity of gender, sexual orientation, relationship status, and body image concerns. SHIFT is novel, patient-centered digital application to address sexual dysfunction in HSCT survivors. Iterative feedback from key stakeholders including HSCT survivors guided SHIFT adaptation and refinement, to optimize patient engagement and ensure inclusivity. The final prototype of SHIFT was initially acceptable to key stakeholders and is now under further testing in a pilot randomized trial to assess its feasibility and preliminary efficacy for improving sexual health outcomes in HSCT survivors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
设计和开发多模式数字干预(SHIFT App),解决造血干细胞移植(HSCT)幸存者的性功能障碍问题。
背景:造血干细胞移植(HSCT)幸存者经常出现持续性功能障碍,这与生活质量(QOL)下降和心理压力增加有关。由于缺乏具有性健康专业知识的临床医生,限制了解决造血干细胞移植幸存者性健康问题的能力。数字健康应用可为解决癌症幸存者的性健康问题提供以患者为中心的可扩展解决方案。本报告旨在描述将面对面的性健康干预改编为名为 "移植后的性健康和亲密关系(SHIFT)"的自我管理数字应用程序的迭代过程,以及利用利益相关者的反馈对 SHIFT 进行改进的过程:我们采用五步开发模式对 SHIFT 进行改编,其中包括1)实施多模式生物-心理-社会概念框架;2)开发综合干预手册和 SHIFT 内容;3)将干预手册转化为互动故事情节,重点是提高患者参与度;4)创建 SHIFT 初步线框;5)通过迭代 alpha 和 beta 测试完善 SHIFT。在每个步骤中,包括造血干细胞移植幸存者、造血干细胞移植临床医生以及性健康、心理学和数字健康专家在内的主要利益相关者都提供了迭代反馈:结果:在每个应用程序开发阶段,我们都根据概念框架、之前的现场干预工作以及利益相关者的迭代反馈对 SHIFT 进行了调整。SHIFT整合了医疗信息、教育材料、亲密关系练习和活动,以解决造血干细胞移植幸存者性健康问题的多种病因。SHIFT还采用了游戏化、个性化以及加入造血干细胞移植幸存者和临床医生视频等策略来提高参与度。根据利益相关者的反馈,我们对 SHIFT 进行了改进,重点关注性别、性取向、关系状况和身体形象问题:SHIFT是一款新颖的、以患者为中心的数字应用程序,用于解决造血干细胞移植幸存者的性功能障碍问题。来自包括造血干细胞移植幸存者在内的主要利益相关者的迭代反馈指导了 SHIFT 的调整和完善,以优化患者参与度并确保包容性。SHIFT 的最终原型初步获得了主要利益相关者的认可,目前正在试点随机试验中进行进一步测试,以评估其在改善造血干细胞移植幸存者性健康结果方面的可行性和初步疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
15.60%
发文量
1061
审稿时长
51 days
期刊最新文献
Advanced Practice Providers in Cellular Therapy: survey results from the ASTCT APP Special Interest Group exploring clinical roles, compensation and job satisfaction. Healthcare resource utilization and associated costs in patients with chronic graft-versus-host disease post allogeneic hematopoietic stem cell transplantation in England: HCRU and associated costs in patients with cGvHD in England. Superior survival after unrelated allogeneic stem cell transplantation with low-dose ATG compared to low-dose TBI in myeloablative fludarabine/busulfan-based regimen for MDS on behalf of the adult MDS Working Group of the JSTCT. N-803, an IL-15 superagonist complex as maintenance therapy after allogeneic donor stem cell transplant for acute myeloid leukemia or myelodysplastic syndrome; a Phase 2 trial. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1